JOURNAL OF CHILEAN CHEMICAL SOCIETY

Vol 61 No 1 (2016): Journal of the Chilean Chemical Society
Original Research Papers

LIQUID CHROMATOGRAPHIC DETERMINATION OF SOLIFENACIN SUCCINATE, FLAVOXATE HYDROCHLORIDE AND TOLTERODINE TARTRATE IN BULK DRUGS AND THEIR PHARMACEUTICAL DOSAGE FORMS

PDF
  • Ali K. Attia,
  • Eman Y. Z. Frag,
  • Gehad G. Mohamed,
  • Heba E. Ahmed
Ali K. Attia
National Organization for Drug Control and Research, P.O. Box 29, Cairo
Eman Y. Z. Frag
Chemistry Department, Faculty of Science, Cairo University, Giza 12613
Gehad G. Mohamed
Chemistry Department, Faculty of Science, Cairo University, Giza 12613
Heba E. Ahmed
National Organization for Drug Control and Research, P.O. Box 29, Cairo
Published December 10, 2015
Keywords
  • Solifenacin succinate,
  • Flavoxate HCl,
  • Toltoridine tartarate,
  • RP-HPLC
How to Cite
Attia, A. K., Frag, E. Y. Z., Mohamed, G. G., & Ahmed, H. E. (2015). LIQUID CHROMATOGRAPHIC DETERMINATION OF SOLIFENACIN SUCCINATE, FLAVOXATE HYDROCHLORIDE AND TOLTERODINE TARTRATE IN BULK DRUGS AND THEIR PHARMACEUTICAL DOSAGE FORMS. Journal of the Chilean Chemical Society, 61(1). Retrieved from https://www.jcchems.com/index.php/JCCHEMS/article/view/41

Copyright (c) 2016 Ali K. Attia, Eman Y. Z. Frag, Gehad G. Mohamed, Heba E. Ahmed

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Abstract

A simple, precise, specific and accurate reversed phase HPLC (RP-HPLC) method has been developed for the determination of solifenacin succinate (SOLS), flavoxate HCl (FLXHC) and toltoridine tartarate (TOLT) in bulk and pharmaceutical dosage forms. The proposed RP-HPLC method was carried out using Xterra RP-18 column (5 μm practical size, 25 cm x 4.6 mm i.d.). The flow rate, the injection volume and the detection wavelength were 1.0 mL/min, 20 mL and 200 nm, respectively. The mobile phase consisted of 0.05 M pentane sulfonic acid sodium salt (SOLS: pH 3.0±0.05, FLXHC and TOLT: pH 5.5±0.05) and acetonitrile (50:50 v/v). The retention times for SOLS, FLXHC and TOLT drugs were found to be 4.1±0.1 min, 4.3±0.0 min and 5.8±0.1 min, respectively. The calibration was linear over the concentration range of 0.1-100 μg/mL. The mean recoveries for SOLS, FLXHC and TOLT drugs were about 99.80%, 100.43% and 100.00%, respectively. The method was validated according to the ICH guidelines with respect to specificity, linearity, accuracy, precision and robustness.

PDF

References

  1. -M. Maniscalco, D. S. Franco, W. R. Wolowich, R. T. Colon, Clin. Ther. 28, 1247, (2006).
  2. -K. J. Kreder, Urol. Clin. North Am. 33, 483, (2006).
  3. -S. C. Sweetman, Martindale, The Complete Drug Reference, 36th ed. Pharmaceutical Press, London, 2009.
  4. -B. K. Malhotra, P. Glue, K. Sweeney, R. Anziano, J. Mancuso, P. Wicker, Clin. Pharmacol. Therap. 81, 377, (2007).
  5. -M. J. O. Neil, The Merck index, An Encyclopedia of Chemicals, Drugs and Biological. 14th ed. New Jersey: Merck Research Laboratories, Whitehouse station, 2006.
  6. -B. V. R. Reddy, B. S. Reddy, N. V. V. S. S. Raman, R. K. Subhash, C. Rambabu, J. Chem. 2013, 1, (2013).
  7. -M. M. Annapurna, G. Sowjanya, M. S. Naidu, D. Lohithasu, Chem. Sci. Trans. 3, 602, (2014).
  8. -V. Vijayasree, D. A. Kumar, J. V. L. N. S. Rao, Pharmanest 4, 206, (2013).
  9. -S. R. Krishna, B. M. Rao, N. S. Rao, J. Chromatogr. Sci. 48, 807, (2010).
  10. -N. Desai, S. H. Syed, S. G. Vasanthraju, A. Karthik, N. Udupa, Int. J. Pharm. Pharm. Sci. 3, 70 (2011).
  11. -D. S. Israel, K. Krishnachaitanya, D. Gowrisankar, IJPSR, 4, 4343, (2013).
  12. -N. Paliwal, P. Jain, N. Dubey, S. Sharma, S. Khurana, R. Mishra, S.K. Paliwal, Int. J. Drug Dev. Res. 5, 91, (2013).
  13. -P. S. Babu, SK. R. Parveen, K. B. Chandrasekar, B. R. Challa, B. Z. Sh. Awen, JSRR, 3, 1905, (2014).
  14. -S. B. Puttagunta, R. P. Shaik, C. K. Bannoth, B. S. R. Challa, B. Z. Sh. Awen, J. Anal. Sci. Tech. 5, 1, (2014).
  15. -T. Oki, S. Sato, K. Miyata, S. Yamada, British J. Pharmacol. 145, 219, (2005).
  16. -D. Desai, G. Mehta, D. Ruikar, R. A Jain, S. J. Rajput, Asian J. Pharm. Biol. Res. 1, 310, (2011).
  17. -S. B. Wankhede, K. Somani, S. S. Chitlange, Int. J. Chem. Tech. Res. 3, 2003, (2011).
  18. -M. V. Attimarad, N. S. Harsha, R. S. Setty, J. Liq. Chromatogr. Rel. Tech. 35, 768, (2012).
  19. -A. El-Gindy, R. A. Abdel-Salam, S. Sallam, Drug Dev. Ind. Pharm. 34, 1311, (2008).
  20. -A. Mahesh, J. Young Pharm. 2, 280, (2010).
  21. -R. N. El-Shaheny, N. M. El-Enany, F. F. Belal, Anal. Methods 6, 1001, (2014).
  22. -S. A. Kumar, M. Debnath, J. V. L. N. S. Rao, Int. J. Pharm. Pharm. Sci. 5, 665, (2013).
  23. -S. K. R. Parveen, P. S. Babu, K. B. Chandrasekar, B. R. Challa, Der Pharmacia Lett. 6, 246, (2014).
  24. -N. Ramathilagam, M. Meeradevi, P. Solairaj, S. C. Rajesh, Int. J. Pharm. Bio. Sci. 2, 332, (2012).
  25. -S. K. Shetty, A. Shah, Int. J. Pharm. Tech. Res. 3, 1083, (2011).
  26. -S. R. Krishna, B. M. Rao, N. S. Rao, Rasayan J. Chem. 2, 144, (2009).
  27. -S. M. Mhamunkar, R. Y. Vyavaharkar, S. Bhoir, Int. J. Pharm. Pharm. Sci. 4, 319, (2012).
  28. -M. V. B. Rao, B. C. Reddy, T. S. Rao, J. R. Mohanty, Res. J. Pharm. Bio. Chem. Sci. 1, 136, (2010).
  29. -R. Yanamandra, C. S. Vadla, U. Puppala, B. Patro, Y. L. N. Murthy, P. A. Ramaiah, Sci. Pharm. 80, 101, (2012).
  30. -G. D. Teja, Ch. D. Dasu, P. S. Babu, P. Ravisankar, JCPS, 6, 195, (2013).
  31. -R. Seetharaman, K. S. Lakshmi, Int. J. Res. Pharm. Biomed. Sci. 2, 1052, (2011).
  32. -M. Attimarad, J. Basic Clin. Pharm. 2, 53, (2011).
  33. -M. Attimarad, J. Iranian Chem. Soc. 9, 551, (2012).
  34. -S. K. Shetty, A. Shah, IJPSR, 2, 1456, (2011).
  35. -S. Vanilatha, M. M. Theresa, N. Prasanna, D. S. Kumari, B. Harika, P. Sirisha, M. A. Xavier, K. G. B. Kumari, IJSID, 1, 288, (2011).
  36. -S. M. Fraihat, H. S. Khatib, Asian J. Chem. 25, 1887, (2013).
  37. -M. S. Rizk, F. M. Abdel-Haleem, Electrochim. Acta 55, 5592, (2010).
  38. -M. M. Sakr, R. M. El Nashar, Talanta 96, 153, (2012).
  39. -M. W. Nassar, K. A. Attia, H. M. Abou-Seada, A. E. Allam, IJPSR, 4, 3845, (2013).
  40. -M. M. Ghoneim, M. A. El-Attar, S. A. Razeq, Central Eur. J. Chem. 5, 496, (2007).
  41. -D. Kul, J. Anal. Chem. 69, 970, (2014).
  42. -P. Macikova, J. Skopalova, P. Cankar, B. Papouskova, R. Strakova, D. Jirovsky, V. Maier, Electroanalysis 25, 205, (2013).
  43. -ICH, Stability Testing of New Drug Substances and Products. International Conference on Harmonization, IFPMA, Geneva, 1993.

Copyright @2019 | Designed by: Open Journal Systems Chile Logo Open Journal Systems Chile Support OJS, training, DOI, Indexing, Hosting OJS

Code under GNU license: OJS PKP